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Gadolinium(III) nanoconjugate constrast agents (CAs) have distinct advantages relative to their 
small molecule counterparts in magnetic resonance imaging (MRI). In addition to increased 
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Gd(III) payload, a significant improvement in contrast enhancement efficiency, or relaxivity (r1) 
is often observed. In this work, we describe the synthesis and characterization of a new class of 
nanoconjugate CAs, created by covalent attachment of Gd(III) to thiolated DNA (Gd(III)-DNA), 
followed by surface conjugation onto gold nanostars (DNA-Gd@stars). These conjugates exhibit 
remarkable r1 with values up to 98 mM
-1 s-1. Additionally, DNA-Gd@stars show efficient 
Gd(III) delivery and biocompatibility in vitro and generate increased contrast enhancement when 
imaged at 7 T. Using nuclear magnetic relaxation dispersion (NMRD) analysis, we attribute the 
high performance of the DNA-Gd@stars to an increased contribution of second-sphere relaxivity 
compared to that of spherical CA equivalents (DNA-Gd@spheres). Importantly, the surface of 
the gold nanostar contains Gd(III)-DNA in regions positive, negative, and neutral curvature. We 
hypothesize that the proton relaxation enhancement observed results from the presence of a 
unique hydrophilic environment produced by Gd(III)-DNA in these regions, which allows 
second-sphere water molecules to remain adjacent to Gd(III) ions for up to ten times longer than 
diffusion. Therefore, this work establishes that particle shape is an important consideration in the 
design of Gd(III) nanoconjugate CAs. 
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MRI is considered an integral part of medical diagnostic imaging due to its high 
spatiotemporal resolution, excellent soft tissue contrast, and exceptional safety profile.2-4 Using 
this technique, high-resolution anatomical images can be obtained without radioactive tracers or 
ionizing radiation. When native contrast is insufficient for definitive detection, CAs are used to 
differentiate among areas where specific anatomical detail is difficult to resolve. To address this 
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shortcoming, paramagnetic chelates of Gd(III) are used to shorten the longitudinal relaxation 
times (T1) of proximal water protons in regions of agent accumulation, and thereby generate 
positive image contrast.5 However, due to the relatively low sensitivity of clinically approved 
small molecule agents, applications are limited because high doses are often required (mM for 
Gd(III) complexes). To increase the utility of magnetic resonance (MR) CAs, current work has 
focused on developing strategies for specific delivery (greater accumulation of Gd(III) at the site 
of interest), and greater proton relaxation efficiency (improved r1 relaxivity).  
Optimizing CA Performance The Solomon Bloembergen Morgen (SBM) theory of 
relaxivity describes three primary ways in which a Gd(III) agent can be optimized: i) changing 
the rotational correlation time, τr, ii) increasing the rate of water exchange with the lanthanide 
(the inverse of the inner-sphere water exchange rate, 1/kex, or τm), and iii) increasing the number 
of coordinated water molecules, q.6-8 Despite numerous examples of Gd(III) chelates bearing 
increased values of q to augment r1, most CA research focuses on complexes wherein q = 1. 
9, 10 
Improving r1 by Optimizing τr Of the aforementioned parameters used to increase r1, the 
most commonly applied is modulation of τr. Increasing this correlation time (by slowing the 
Gd(III) reorientation time) is known to improve CA r1 significantly at magnetic field strengths ≤ 
1.5 T (corresponding to proton Larmor frequencies of ≤ 64 MHz). The effects of changing this 
parameter at higher field strengths, however, is unsubstantial or sometimes detrimental to CA 
performance.6 Often, increasing τr is achieved by immobilization of Gd(III) to a nanoparticle or 
macromolecule. This approach is particularly common because nanoconjugate CAs are 
chemically accessible, and couple the tumbling rate of the Gd(III) chelates to that of the much 
larger species. In addition to increased r1, this strategy is beneficial for increased local 
concentrations of CA (high Gd(III) payload per particle). For this reason, a variety of Gd(III) 
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nanoconjugate CAs have been described, including agents based on biomacromolecules (proteins 
and viruses), organic nanoparticles (nanodiamonds, liposomes and polymers), and inorganic 
nanoparticles (silica, titanium and gold). 11-21  
Recently, Gd(III)-DNA was attached to spherical gold nanoparticles, creating Gd(III) 
enriched DNA gold nanoparticle conjugates (DNA-GdIII@AuNP).22 This nanoconjugate design 
was particularly effective for cellular MR imaging because DNA-GdIII@AuNPs showed both 
improved r1 relaxivity per Gd(III) and higher cellular internalization of Gd(III) relative to their 
small molecule counterparts. Importantly, the nanoconjugates delivered the expected increase in 
r1 by lengthening of τr, while maintaining the high stability, nuclease resistance, biocompatibility 
and efficient cell uptake conferred by the densely packed monolayer of DNA on the gold 
nanoparticle surface. 23-25 Attempts to increase r1 further by increasing the particle size, however, 
showed only minor improvement.22  
Improving r1 by Optimizing τm Another commonly used approach for improved r1 
described by SBM theory focuses on the rapid and efficient exchange of water within the inner-
sphere of Gd(III) complexes (τm), a feature which is critical to the generation of high T1 
contrast.26-29 However, SBM simulations suggest that a significant enhancement of r1 using this 
strategy is only probable in CAs bearing near optimal values of τr, particularly at low field 
strengths (≤ 1.5 T).30 By virtue of their size, nanoconjugate CAs inherently possess relatively 
slow tumbling rates. For this reason, improvement of r1 in nanoconjugate systems, where q is 
held constant, is readily accessible through the optimization of τm.  
In Gd(III) CA systems, T1 proton relaxation is dominated by a dipole-dipole mechanism.
31 
Within the equations that describe this behavior, the correlation time parameter, τc, is a field 
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strength dependent variable which contains features of Gd(III) complexes that can be affected by 












    (1) 
where T1e is the electronic spin relaxation time, τr is the rotational correlation time and τm is the 
inner-sphere water exchange rate. When τc
-1
 is equal to 2π times the proton Larmor frequency, r1 
will be equal to its maximum value achievable at that frequency. Predicting and affecting T1e 
experimentally is not straightforward, thus, approaches to CA optimization commonly focus on 
modulation of τr and τm.
32 In nanoconjugate CAs, the particle τr often exceeds tens of 
nanoseconds, and therefore τc is dominated by the shorter of T1e or τm, or both if of similar 
length. Typical values of T1e between 0.5-1.5 T are approximately 10 ns. In this range of 
magnetic field strengths, the optimal τm value varies from 20 ns at 0.5 T, to 5 ns at 1.5 T, and 
therefore an optimized CA will possess a τm within this range. 
30 
Gd(III) Nanoconjugates and Second-Sphere Relaxivity The water exchange kinetics of 
lanthanide complexes is a direct result of the metal-ligand coordination environment. Therefore, 
improvements to τm are readily observed by synthetic modification of the Gd(III)-ligand complex 
prior to particle conjugation.33-35 Alternately, recent work has suggested that confinement of a 
CA on or near a nanoparticle or protein surface may affect the diffusion of water in the proximity 
of the CA, and thereby impact its performance by providing a significant second- and outer-
sphere relaxivity enhancement.36 Although second- and outer-sphere contributions to relaxivity 
are generally considered insignificant due to the high rate of water diffusion past the Gd(III), this 
phenomenon is sometimes cited to explain unexpectedly high values of r1 in nanoconjugate 
systems.6, 19, 30, 37, 38  
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We predict that this behavior can be affected experimentally by altering the water diffusion 
adjacent to hydrophilic nanoparticle surfaces, and that this may provide a new design parameter 
for improved r1 in Gd(III) nanoconjugate CAs. We hypothesize that nanoconjugate CA surface 
dynamics can be affected by variation in particle shape, and that this alternation can be used to 
augment r1 through the enhancement of second-sphere contributions to CA performance. In 
support of this rationale, recent work has shown that the surface curvature of irregularly shaped 
nanoparticles can significantly affect the chemical reactivity of surface ligands.39 In an effort to 
create a high relaxivity CA, we have examined the effects of particle size and shape within the 
Gd(III)-DNA gold nanoconjugate platform using gold nanostars to produce DNA-Gd@stars 
(Scheme 1). Importantly, the nanostar particle surface contains regions of positive, negative, and 
neutral curvature, and thus we predict a significant effect on the local environment of the surface 




Scheme 1. Preparation of DNA-Gd@stars. (a) A Cy3-labeled 24-mer poly dT oligonucleotide 
is modified via the covalent attachment of Gd(III) to each of 5 azide-bearing dT bases per 
strand. (b) The functionalized oligonucleotide is deprotected, revealing the 3’ thiol and is 
conjugated to nanostars through a series of increases in salt concentration called salt aging.1 
Herein, we present the synthesis of a new τm-optimized, alkyne-bearing Gd(III) chelate to 
ensure that r1 relaxivity is not limited by inner-sphere water exchange.
40 When the Gd(III) 
complex is conjugated to the surface of gold nanostars, DNA-Gd@stars achieve r1 relaxivities up 
to 98 mM-1s-1, a 25-fold greater r1 relaxivity than FDA-approved chelates at 25 °C (32 MHz). 
Significantly, these values exceed the theoretical maximum relaxivity predicted by SBM theory 
when a single water molecule is coordinated to the Gd(III) (q =1).30  
Employing detailed NMRD analysis, we compare 15-nm DNA-Gd@spheres with the DNA-
Gd@stars and demonstrate that their proton relaxation efficiency is the result of optimized inner-
sphere water exchange kinetics, and particle surface-mediated elongation of second-sphere water 




Scheme 2.  Chemical synthesis of τm-optimized Gd(III) complex(5). Synthesis of (1) 
proceeds through reaction of acryloyl chloride and propargylamine (Scheme S1). Conjugation 
of the propionate arm to tert-Butyl DO3A (2) is achieved by 1,4 conjugate addition in ACN 
over 3 days. Deprotection of the macrocycle (4) in trifluoroacetic acid is followed by 
metalation by GdCl3 at pH 5.5 for 12 h and HPLC purification. 
RESULTS AND DISCUSSION 
Synthesis and Characterization of a τm-Optimized Gd(III) Complex The water exchange 
kinetics of lanthanide complexes can be affected by interchange of ligand types or synthetic 
modifications thereof. 41 Recent work using the macrocyclic ligand [1,4,7-(tris-tert-butyl 
acetate)-1,4,7,10-tetraazacyclododecane], or DO3A, has described a modification shown to 
increase steric crowding around the water coordination site, thereby shortening τm.
35, 42 Using 
this previously reported strategy to facilitate an optimal τm in our nanoconjugate system, a new 
ligand based on DO3A was synthesized (Scheme 2). Importantly, a pendant alkyne is present to 
facilitate conjugation using click chemistry. Linker arm 1 was synthesized from acryloyl chloride 
and propargylamine in 72% yield. Attachment of 1 to previously synthesized DO3A macrocycle 
2 proceeds via a 1,4 conjugate addition in the presence of base over 3 days.43 Deprotection of 
compound 3 in trifluoroacetic acid generates the triacetate ligand 4 (Scheme S3), and metalation 
followed by reverse phase high pressure liquid chromatography (RP-HPLC) purification resulted 
in a 65% yield of the Gd(III) complex 1-(N-(prop-2-yn-1-yl)2-oxopropyl)-4,7,10-
tris(carboxymethyl)-1,4,7,10-tetraazacyclododecyl-gadolinium(III) (5).  
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To determine the τm of complex 5, a variable temperature 
17O titration was performed. 
Results were fitted to the SBM equations and a τm of 22 ns at 37 °C was observed.
31 This result 
represents an improvement of nearly 680 ns from the previously described Gd(III) complex in 
DNA-GdIII@AuNPs (Figure S1).31 The successful optimization of this parameter is particularly 
significant because in cases where τm << T1 (a scenario known as a ‘fast exchange’ regime), 
inner-sphere water molecules account for the greatest contribution to r1 by efficiently 
transmitting the relaxation enhancement of the Gd(III) coordinated water molecules to the bulk.30 
To verify the number of inner-sphere water molecules (q), the Eu(III) analog of complex 5 
was synthesized (complex 6, Scheme S4). Using the modified Horrocks’ method, equimolar 
solutions of 6 in water and D2O were prepared and luminescence lifetimes of each solution were 
recorded and fitted, resulting in a q = 1.1 ± 0.1 (Figure S2). 44, 45 
Synthesis and Characterization of DNA-Gd@stars Synthesis of Gd(III) labeled DNA 
began by incorporation of a C6 amino modified deoxythymidine (dT) nucleotide into five 
positions along the 24-mer poly dT oligonucleotide sequence (Scheme 1, Scheme S6). The 3’-
thiolated 24-mer (5x amino modified) poly dT - Cy3 - 5’ was reacted with azidobutyrate N-
hydroxy succinimide ester in the presence of base to install the azide functionality. Finally, 
complex 5 was covalently attached to the poly azido DNA via a Cu(I) catalyzed 1,3 dipolar 
cycloaddition (CuAAC, or ‘click’ chemistry). The successful synthesis of the 3’ thiolated Gd(III) 
poly dT-Cy3-5’ oligonucleotide was subsequently confirmed by matrix assisted laser desorption 





Figure 1. Absorbance spectra of nanostars (dashed line) and DNA-Gd@stars (solid line) 
indicate an 18 nm resonance shift after functionalization. Insets are a TEM image of nanostar 
and scheme indicating nanostar curvature.  
Synthesis of nanostars was performed by the reduction of chloroauric acid by 4-(2-
Hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES) buffer.46, 47 DNA-Gd@Star conjugates 
were synthesized by salt aging purified Gd(III)-DNA in water over three days (Scheme 1). 
Purified particles appear dark green due to the plasmon resonance at 800 nm and are stable in 
water for >12 weeks when stored at 4 °C. 
Transmission electron micrographs (TEM) (Figure 1, inset) show that DNA-Gd@stars 
contain multiple (up to 8) branches, have an average tip-to-tip diameter of ca. 50 nm, and an 
approximate volume of 1.6×104 nm3 (supporting information). Significantly, individual particles 
possess regions of positive (branch tips) and negative curvatures (between branches), and flat 
regions (branch length) (Figure 1). Upon functionalization with Gd(III)-DNA, the average 
hydrodynamic diameter of nanostars increased from 38.8 ± 0.1 nm to 63.0 ± 0.7 nm (Table S1) 
and the maximum surface plasmon absorbance wavelength shifted from 800 nm to 818 nm, 
indicating that the Gd(III)-DNA was successfully conjugated to the nanostar surface and that 
colloidal stability is maintained (Figure 1). A critical feature for biological applications, the 
Gd(III)-DNA coating was effective in stabilizing DNA-Gd@stars under a range of salt (0-450 
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mM NaCl) and pH (pH 3-11) conditions, and in cell culture media (DMEM + 10% FBS) (Figure 
S4). 
To quantify DNA loading, inductively coupled plasma mass spectrometry (ICP-MS) was 
used to determine the ratio of Gd(III) to Au. DNA-Gd@stars contained 1990 ± 450 Gd(III) 
complexes per nanostar, corresponding to 398 ± 90 DNA strands per nanostar. This loading 
represents greater than a three-fold increase in Gd(III) payload relative to DNA-Gd@spheres due 
to larger particle size, and is comparable in Gd(III) payload relative to the DNA-Gd@spheres40nm 
(Table S1). The number of gold atoms per particle is approximated by calculating the nanostar 
volume in >180 particles using TEM and the density of bulk gold (supporting information).  
Molar Relaxivity of DNA-Gd@stars To assess the performance of DNA-Gd@stars, the r1 
of the nanoconjugates was determined by taking the slope of the linear plot of 1/T1 vs. Gd(III) 
concentration (Table S3, Figure S5). The surprising value of 54.7 mM-1 s-1 per Gd(III) in water at 
60 MHz and 37 °C was obtained (the average of multiple batches, Table S2). This value is 
among the highest reported for a Gd(III)-nanoconjugate (for one inner-sphere water molecule, or 
q = 1) and is in the same range as supramolecular- or protein-bound Gd(III) complexes. Similarly 
high values of r1 are observed for Gd(III) conjugated to viral capsids, non-covalently bound to 
human serum albumin (MS-325), or entrapped in apoferritin.15, 48, 49  
To investigate the source of such high r1 values, the relaxivities of the unconjugated Gd(III) 
complex (Scheme 2), and DNA-bound Gd(III) were examined separately. The r1 of complex 5, 
and unconjugated Gd(III)-DNA were found to be 3.8 mM-1 s-1 and 9.5 mM-1 s-1, respectively 
(Table 1). Though incrementally higher than equivalent values using the previously described 
Gd(III) complex (7), the relaxivities observed were unremarkable.22 In order to validate the high 
relaxivity of the assembled nanostar constructs, five replicate batches of DNA-Gd@stars were 
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synthesized and measured, showing relaxivities between 42.3 and 69.1 mM-1 s-1 (37 °C, 60 
MHz), and Gd(III) loading between 1231 and 2473 Gd(III) per particle (Table S2). For the 
purpose of comparison, spherical conjugates were synthesized using the same Gd(III)-DNA 
(DNA-Gd@spheres and DNA-Gd@spheres40nm) (Figure S3).
1. When examined at low field 
strength (where differences in r1 are most evident, here 1.41 T),
30 r1 relaxivities measured only 
14.6 mM-1 s-1 and 16.8 mM-1 s-1, respectively. Taking the product of the particle loading (Table 
S1) and high r1 per Gd(III), DNA-Gd@stars exhibit a three-fold greater relaxivity per particle 
relative to DNA-Gd@spheres40nm, despite comparable Gd(III) payload. These results (Table 1) 





Table 1. Relaxivities of DNA-Gd@stars and DNA-Gd@spheres at 60 and 300 MHz. ‘Ionic’ r1 
refers to the contribution of each individual Gd(III) complex to proton relaxation, whereas 
‘particle’ describes the product of each particle’s payload and ionic r1. 
 r1 relaxivity (mM
-1 s-1) 
 60 MHza 300 MHzb 
ProHance 3.0c 4.0 
Complex 5 3.8 NM 
Gd(III)-DNA 9.5 NM 
DNA-Gd@stars /ionic 54.7 9.4 
DNA-Gd@stars /particle 108850 19345 
DNA-Gd@spheres /ionic 14.6 5.8 
DNA-Gd@spheres /particle 8230 3270 
DNA-Gd@spheres40nm /ionic 16.8 NM 
DNA-Gd@spheres40nm /particle 34520 NM 
ameasured at 37 °C in water plus 0.01% tween 20. bmeasured at 25 °C in  
water plus 0.01% tween20 cas previously reported50 NM = not measured 
 
High-Field r1 of DNA-Gd@stars As the demand for improved contrast-to-noise ratios and 
image resolution continues to grow, research has trended toward the use of higher field strength 
MR instruments.3 As a consequence, Gd(III) contrast agent performance at high-field is 
becoming increasingly important. To demonstrate the ability of DNA-Gd@stars to increase T1 
contrast at high magnetic fields, solution phantoms were acquired on a 7 T Bruker PharmaScan 
(300 MHz). DNA-Gd@star samples were imaged at varying concentrations, and the T1 
relaxation times of each tube were used to calculate high-field relaxivity. DNA-Gd@stars 
generated an r1 of 9.4 mM
-1 s-1, while the r1 of the commercially available CA, ProHance, was 
only 4.0 mM-1 s-1 at 25 °C in water (Figure 2). Solutions of ProHance at the concentrations 
examined (equimolar in Gd(III) with DNA-Gd@stars) showed contrast enhancement 




NMRD Acquisition For a detailed mechanistic investigation into the cause of the very high 
relaxivities observed, DNA-Gd@stars and DNA-Gd@spheres were subjected to a nuclear 
magnetic relaxation dispersion (NMRD) analysis. Due to the small difference in r1 observed 
between the different sizes of spherical nanoconjugates at 1.41 T, only the 15-nm DNA-
Gd@spheres (which most closely resemble the DNA-gold nanoparticle conjugates in literature) 
were taken forward for NMRD comparison to DNA-Gd@stars.1, 22-25, 51-53 Using this technique, 
proton T1 relaxation rates of water are observed in the presence of paramagnetic species across a 
range of magnetic field strengths. With the acquired data, proton relaxivity profiles are created 
and fitted using SBM theory or other more recently developed approaches such as the modified 
Florence model.54-56 The analysis of relaxivity profiles provides a means of extracting valuable 
mechanistic information, including dynamic parameters such as τr and τm.
31, 57-59  
The NMRD profiles of the nanostar and 15-nm spherical nanoparticle conjugates were 
measured at 25 °C and 37 °C in water. After acquisition, spectra were normalized to the Gd(III) 
concentration, and the resulting relaxivity profiles were analyzed using the modified Florence 
model and the independently measured values for τm  and q (Figure 3).
54, 55, 60, 61  
 
 
Figure 2. High-field MR solution phantoms (25 °C, 7 T) of aqueous solutions of DNA-
Gd@stars vs. equimolar concentrations of the clinical CA ProHance (standardized to 
[Gd(III)]). Approximate diameter of capillary tubes=1 mm. Calibration bar is signal intensity. 
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NMRD Analysis The NMRD profile of DNA-Gd@stars shows a maximum relaxivity peak 
of 98 mM-1 s-1 at 25 °C, centered at approximately 32 MHz. This very large value exceeds the 
theoretical limit that can be calculated with SBM theory, including that calculated with the 
modified Florence model, when only one water molecule is coordinated to the Gd(III) ion 
(Figure S13).30  
As a consequence, this profile could not be reproduced by constraining q = 1. Even when 
including contributions from the outer coordination sphere (water molecules freely diffusing up 
to a distance of closest approach of 3.6 Å), the data could not be fit.62, 63 Allowing the analysis to 
consider a value of q > 1 was observed to provide the best fit of the NMRD data. This is a 
physically unlikely scenario, however, because neither the attachment of the Gd(III) complex to 
the DNA, nor conjugation to the gold nanoparticle is expected to affect the coordination 
environment of the Gd(III) and affect q.50 To rationalize these results, the analysis was 
reformulated so that q = 1, but was made to include both the previously added outer-sphere 
contributions and significant contributions from second coordination sphere water molecules.64, 
65 In this analysis, the τr of the DNA-Gd@stars is assumed to be larger than T1e and τm (τr ≥ 1 μs), 
and thus beyond the ability to affect r1 significantly. As a result, four second-sphere water 
 
 
Figure 3. NMRD profiles for water solutions of DNA-Gd@stars and DNA-Gd@spheres. 
Best fit parameters for the profiles are reported in Table S12 and S13. 
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molecules (qSS = 4) at a Gd(III)-proton distance of 3.5 Å were required to fit the data 
successfully. This interpretation required an exceptionally large contribution to r1 from the 
second-sphere water molecules, which is unusual because in most Gd(III) complexes this 
contribution is <10% of total r1.
30 Due to the covariance between qSS and the Gd(III)-proton 
distance, larger values of qSS are feasible for even larger proton distances. 
By definition, the magnitude of second-sphere effects on r1 is determined by the number of 
second-sphere water protons, their distance from and residency lifetimes adjacent to the metal 
center. In most cases, the second-sphere water molecule lifetimes (τm
SS) are sufficiently short 
that their contributions to the bulk paramagnetic relaxivity is small, and therefore these effects 
are accounted for by combining the second-sphere contribution with the outer-sphere relaxation 
(when their residence times adjacent to the metal are at or near the diffusional residence time). In 
order to obtain the large contribution from the second-sphere water molecules in the DNA-
Gd@stars, τm
SS is requisitely assigned relatively long values (0.1-1 ns) compared to diffusion 
(tens of picoseconds). Based on this analysis, we hypothesize that the shape of the DNA-
Gd@stars provides a unique, hydrophilic microenvironment where an extended network of 
transiently associated second-sphere water molecules can reside adjacent to the Gd(III). Many 
recent examples of nanoconjugate CAs appear to support this hypothesis, though in many cases 
we find that it is not described explicitly.15, 19, 48, 49 
While seldom investigated in mechanistic detail, nanoconjugate CAs that exhibit unusually 
high r1 relaxivities often mention the chemical environment of the Gd(III) as a possible 
explanation. In particular, for CAs that bear extended hydrophilic polymer or protein surfaces, 
the chemical environment surrounding the lanthanide center is believed to slow water diffusion 
in the second-sphere of the Gd(III) complexes.15, 19, 37, 48, 49 The result of this hydrogen bonding-
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rich environment is that each metal center has incrementally longer contact with second-sphere 
water molecules. In extensive work to study the effects of second-sphere relaxivity (r1
SS), 
chelates of Gd(III) were synthesized using pendant phosphate groups.64, 66, 67 Importantly, Gd(III) 
complexes were presented wherein the inner-sphere water was displaced by steric crowding (q = 
0), which allowed for direct experimental determination of second- and outer-sphere relaxivities 
compared to q = 1 controls. In further work, q = 0 chelates of Gd(III) were bound to serum 
albumin (in order to lengthen τr and thereby optimize r1), and could achieve second- and outer-
sphere relaxivities as high as 12 mM-1 s-1 at 20 MHz and 25 °C. This work showed that using 
pendant hydrogen bonding functional groups and an adjacent hydrophilic protein surface could 
facilitate contributions from the second-sphere that are quite significant.68  
The precedent studies and our current results suggest that a sizable contribution to r1 must be 
provided by second-sphere water molecules present in the dense monolayer of DNA on the 
surface of DNA-Gd@stars. This sterically crowded, hydrogen bonding-rich environment likely 
plays a major role in helping to slow the diffusion of passing water molecules in the proximity of 
the Gd(III). 
Investigating r1SS in DNA-Gd@stars For additional evidence to support the second-sphere 
relaxivity hypothesis, the NMRD profile was examined for detailed information about the on-
particle water exchange dynamics by observing the change in relaxivities with respect to 
temperature. A decrease in r1 with increasing temperature is observed in the DNA-Gd@stars, in 
agreement with the ‘fast exchange’ behavior of inner-sphere water molecules observed in the 
exchange dynamics of 5.69 Formally, fast exchange behavior is manifest by a decrease in τc with 
increasing temperature. From the NMRD fit, the T1e at very low fields increases with increasing 
temperature and is about 0.5-1 ns, whereas τr is maintained at values larger than tens of 
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nanoseconds. Therefore, we conclude that the decrease in r1 with increasing temperature is the 
result of a faster τm.  
 
In the NMRD fit, the τm was fixed to the previously measured values of 39 ns and 22 ns at 25 
°C and 37 °C, respectively. The τm
SS, however, was left to vary. After fitting, the respective 
inner-, second- and outer-sphere components of r1 were plotted and analyzed (Figure 4, Table 
S11). The results showed that the contribution to r1 from inner-sphere water molecules was 
almost independent of temperature, despite the nearly two-fold difference in τm between the two 
temperatures. This indicates that the inner-sphere residency time of coordinated water molecules 
is not the major determinant of τc for the dipole-dipole interaction with the Gd(III). 
 
 
Figure 4. Simulated deconvolution of DNA-Gd@stars NMRD profiles into component inner- 




SS values calculated from the NMRD fitting were 0.6 ns and 0.3 ns at temperatures of 
25 °C and 37 °C (Table S12), and were found to be the predominant cause of the observed 
decrease in r1 between the two temperatures (Figure 4b). This change in τm
SS represents a two-
fold change in the exchange rate between the two temperatures, which is similar in magnitude, 
but on a time scale nearly two orders of magnitude more rapidly, than the inner-sphere exchange 
rate (although still slow compared to diffusion). Here, we show that the 44% decrease of r1 with 
increasing temperature is largely determined by second-sphere water proton residence lifetimes 
(Table S11). Specifically, at the clinically relevant field strength of 1.5 T (64 MHz), we find an 
r1
SS of 31.5 mM-1 s-1 of a total 54.8 mM-1 s-1 at 25 °C, and 17.2 mM-1 s-1 of a total 44.3 mM-1 s-1 
at 37 °C (57.4% and 38.8% second-sphere contribution, respectively). For this reason, the r1
SS 
contribution provides a significant increase in the overall performance of the DNA-Gd@stars 
relative to other Gd(III) nanoconjugates. 
NMRD Analysis of DNA-Gd@spheres To verify that the irregular shape of the nanostars is 
responsible for the high relaxivities observed, the 15-nm DNA-Gd@spheres synthesized using 
the same Gd(III)-DNA were studied by NMRD (Figure 3). The spherical particles show a similar 
behavior with respect to temperature (a fast exchange regime), but generate a considerably lower 
r1. The NMRD profile from the spherical nanoparticle system could be fitted using q = 1, where 
most of r1 can be attributed to inner-sphere relaxation (with only minor contributions from the 
second- and outer-sphere). The temperature-dependent difference in r1 is attributed to the less 
optimal reorientation times resulting from increased local mobility, τfast (Table S13).15, 70 The 
effects of local mobility were not included in the analysis of the DNA-Gd@stars because this 
treatment would result in even larger r1
SS (due to faster Gd(III) reorientation times, and thus 




By comparing the NMRD data for the DNA-Gd@spheres and the DNA-Gd@stars, we 
observe that even without the large second-sphere contribution to r1, the Gd(III) nanostar 
conjugates generate an r1
IS of 66.9 mM-1 s-1 at 32 MHz and 37 °C. This value is approximately 
twice the total r1 of the DNA-Gd@sphere conjugates at the same field and temperature. This 
suggests that the shape of DNA-Gd@stars provides a unique environment capable of delivering 
high relaxivities even in the absence of r1
SS. Furthermore, when comparing the r1 of the 15-nm 
DNA-Gd@spheres with that of the 40-nm equivalent at 1.41T (64 MHz), only a minor 
improvement was observed (Table 1). We believe that this evidence further supports our 
hypothesis that the particle shape is a critical factor for the high performance of the DNA-
Gd@stars. 
DNA-Gd@star Cell Uptake and Biocompatibility Due to the impressive r1 observed for 
DNA-Gd@stars, and the precedent that other oligonucleotide-coated nanoparticles are able to 
efficiently enter cells without transfection agents, we believe DNA-Gd@stars are promising CAs 
for applications such as cellular tracking or cancer diagnosis.22, 51 For this reason, we 
investigated the ability of DNA-Gd@stars to deliver Gd(III) to cancer cells in vitro. To examine 
if DNA-Gd@stars maintain the desired cellular uptake and biocompatibility of small spherical 
nanoconjugate platforms that are well characterized in the literature, we did a comparison with 
the 15-nm DNA-Gd@spheres. 22-24, 68 We also compare DNA-Gd@stars to a commercially 
available CA (ProHance).  
In cellular uptake studies, pancreatic cancer cells (PANC-1) were incubated with increasing 
Gd(III) concentrations of DNA-Gd@stars, DNA-Gd@spheres, or ProHance for 24 hours. To 
remove non-internalized CAs, cells were washed 3 times with ice-cold PBS prior to 
trypsinization, then washed an additional 2 times by centrifugation and resuspension in fresh 
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buffer. Finally, cells were counted and digested in a 1:1 mixture of HNO3 and HCl for metals 
analysis using ICP-MS. Results indicated that the Gd(III) payload delivered per cell by 
incubation with DNA-Gd@stars was 50 times higher than incubation with ProHance, and ca. 1.4 
times higher than that by DNA-Gd@spheres (Figure 5b). 
 
Previous reports suggest that between 107-109 Gd(III) ions per cell are required to produce 
detectable contrast in MRI.22 Thus, DNA-Gd@stars delivered Gd(III) payloads that are expected 
to generate visible contrast using only low-micromolar incubation concentrations (4.5×107 ions 
per cell with 6 µM Gd(III) incubation concentration, Batch 5 in Table S2). To check for 
detectable contrast in cell pellet images, PANC-1 cells were incubated with 0, 3 and 6 µM 
Gd(III) concentrations of DNA-Gd@stars or the commercial CA ProHance for 24 hr. After 
washing, cell pellets were added to glass capillary tubes and imaged using a Bruker PharmaScan 
7T (Figure S14). Analysis of the resulting images confirmed that the T1 of cells incubated with 
 
 
Figure 5. (a) Confocal images of DNA-Gd@stars and DNA-Gd@spheres ([Gd(III)]=1.5 µM) 
taken up by PANC-1 cells. Magenta signal represents Cy3-labeled nanoconjugates imaged 
under identical microscope conditions (without post-processing) and blue signal represents 
DAPI stained nuclei. (b) Femtomoles of Gd(III) taken up per cell, quantified by ICP-MS. 
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DNA-Gd@stars were reduced compared to untreated cells and ProHance (p<0.02). These results 
highlight that in addition to significantly improving r1, DNA-Gd@stars efficiently penetrate 
cells, enabling detectable contrast in cell pellets using as low as 3 µM Gd(III) incubation 
concentrations. 
Confocal fluorescence micrographs were obtained to visualize the uptake and intracellular 
localization of DNA-Gd@stars and 15-nm DNA-Gd@spheres in PANC-1 cells (24-h incubation, 
[Gd(III)]=1.5 µM). The fluorescence from the Cy3-labeled conjugates were obtained under 
identical microscope conditions, and were not post-processed, for a more accurate visual 
comparison (Figure 5a). The Cy3 signal of DNA-Gd@stars appears brighter than that of DNA-
Gd@spheres, consistent with the quantitative results gathered by ICP-MS.  
We attribute the difference in Gd(III) delivery primarily to greater loading as a result of the 
higher surface area of the gold nanostars compared to the 15-nm spheres. Interestingly, we 
noticed a difference in the intracellular localization of the two conjugates. DNA-Gd@stars are 
distributed through the cytoplasm of the cells, while the DNA-Gd@spheres are primarily 
localized in the perinuclear region, consistent with the previous generation of DNA-
GdIII@AuNPs.22 Although beyond the scope of the current study, this result suggests that 
differences may exist in the uptake or intracellular trafficking (e.g., endosomal-lysosomal 
pathway) behavior between the star- and spherical-shaped conjugates and warrants further 
investigation into the effects of the nanostar shape and size on cellular interactions.   
Finally, the toxicity of the DNA-Gd@stars and DNA-Gd@spheres conjugates was evaluated 
using the CellTiter 96 MTS assay. After a 24 hour incubation up to 6 µM Gd(III) concentrations, 
no cytotoxicity was observed for either conjugate (Figure S15). Considering the exceptionally 
high r1 of DNA-Gd@stars, these in vitro results demonstrate that this platform is an effective and 
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biocompatible CA for cellular MR imaging that requires only low-µM Gd(III) incubation 
concentrations to generate detectable image contrast.  
CONCLUSION 
The use of MRI for longitudinal, in vivo studies presents clear advantages over competing 
modalities for its safety, soft tissue contrast and limitless depth penetration. As a result, the 
investigation of new Gd(III) CAs has been of great interest to the research community. Herein 
we report a new class of gold nanoconjugates that exhibit exceptionally high relaxivities at both 
low and high field strengths. Using NMRD analysis we have shown that nanoparticle shape and 
surface curvature affect the organization of conjugated DNAs on the particle surface and that this 
plays a meaningful role in sequestration of water molecules in the proximity of the Gd(III) 
complexes. Upon incubation with pancreatic cancer cells, DNA-Gd@stars improve Gd(III) 
delivery and maintain biocompatibility when compared side-by-side with DNA-Gd@spheres and 
commercial CAs. These results indicate the strategic value of designing the Gd(III) chelate into a 
dense, hydrophilic microenvironment to facilitate longer access to second-sphere water 
molecules, and thereby generate contrast enhancement greater than can be achieved using small 
molecule CAs alone. These results will facilitate future nanoconjugate CA development by 
consideration of particle shape and surface chemistry as vital parameters in the proton relaxation 
mechanism of Gd(III) based agents. 
MATERIALS AND METHODS 
Chemical Synthesis and Characterization All reagents and solvents were purchased from Sigma-
Aldrich unless otherwise noted. All chemical synthesis was performed under ambient conditions unless 
described explicitly. Chemical characterization was achieved using a Varian 500 MHz NMR and a Bruker 
AutoFlex III MALDI spectrometer. Ligand and Gd(III) complex purification was performed using a 
Varian Prostar 500 HPLC using a Waters 4.6 × 250 mm 5 µm Atlantis C18 column and mobile phases of 
Millipore water, 0.05% trifluoroacetic acid in Millipore water, and acetonitrile. Nanoparticle 
characterization was performed on JOEL 1230 and Hitachi HD7700 TEMs.  UV/Vis/NIR spectra of 
colloidal solutions were collected on a LAMBDA 1050 spectrophotometer (Perkin Elmer).  DLS and 
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zeta-potential measurements were done with a Brookhaven ZetaPals zeta potential and particle size 
analyzer.  
Oligonucleotides were synthesized on solid phase controlled pore glass beads (CPGs) by standard 
techniques on a MerMade automated synthesizer.  All reagents and protected 3’ thiol modifier CPGs and 
C6 amino modifier dT modified bases were purchased from Glen Research (Sterling, Va).  
Oligonucelotides were deprotected from the solid phase using AMA conditions [(1:1 
methylamine:ammonium hydroxide (sat.)] for one hour. Purification of oligonucleotides was performed 
using reverse phase high performance liquid chromatography (HPLC) on a Varian HPLC using a mobile 
phase consisting of 30mM triethyl ammonium acetate buffer pH 7 (TEAA) and acetonitrile (ACN).  
Separation was achieved using a gradient of 75% Acetonitrile over 45minutes, as monitored by backbone 
and Cy3 wavelengths at 254 and 546 nm respectively. Purified oligonucleotides were lyophilized and 
stored at -20 °C until particle synthesis. Inorganic Gd(III) complex 5 was synthesized using standard 
organic chemistry techniques.   
ICP-MS was performed on either a computer-controlled (Plasmalab software) Thermo (Thermo Fisher 
Scientific, Waltham, MA) PQ ExCell ICP-MS equipped with a CETAC 500 autosampler or a computer-
controlled (Plasmalab software) Thermo X series II ICP-MS equipped with an ESI (Omaha, NE, USA) 
SC-2 autosampler. 
Synthesis of Gold Nanostars: Gold nanostars were synthesized by reducing chloroauric acid in 4-(2-
Hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES buffer) to create biocompatible, surfactant-free 
gold nanoparticles).46 Specifically, chloroauric acid (0.2 mM final concentration) was added to HEPES 
buffer (100 mM), shaken for 1 minute, then left to grow for at least 30 min. The resonance wavelength of 
the nanostars was measured using UV/vis spectroscopy.  
 
Synthesis of Spherical Gold Nanoparticles:  Gold nanoparticles were synthesized by published 
procedures. The plasmon resonance wavelength was observed by UV/Vis spectroscopy and size was 
confirmed by DLS and TEM (Figure S3b). 40-nm unconjugated gold colloids were purchased from Ted 
Pella and characterized by DLS and TEM (Figure S3c). 
Relaxivity (r1):  A stock solution of DNA-Gd@star conjugates was made (700 uL).  This stock was 
serially diluted four times for a total of five solutions. Solutions were heated to 37 °C and two hundred uL 
of each concentration was placed into a Bruker minispec mq60 NMR spectrometer (60 MHz) for 
measurement of T1 relaxation time. Data were collected using an inversion recovery pulse sequence using 
4 averages, a 15s repetition time and 10 data points.  The remaining volumes of each solution were 
utilized for ICP analysis of [Gd(III)].  The inverse of the longitudinal relaxation time (1/T1, s-1) was 
plotted versus the Gd(III) concentration (mM). By applying a linear fit to this data, the slope that is 
generated is defined as the relaxivity of the agent (mM-1 s-1). Relaxivities of DNA-Gd@spheres, Gd(III)-
DNA and complex 5 were collected by the analogous procedure.  
Metals Analysis by ICP-MS: Quantitation of metal concentration was performed by acid digestion of 
nanoconjugate samples, followed by ICP-MS analysis. Gadolinium and gold analyses were prepared by 
different dilution factors such that were within the range of the selected standard concentrations.  
Specifically, Gd analyses were digested by addition of 20 ul of nanoconjugate sample into 120 ul of 1:1 
concentrated nitric acid: concentrated hydrochloric acid (TraceSelect Nitric acid, >69% ; TraceSelect 
HCl, fuming 37%) and mixed thoroughly. Au analyses were made by addition of 5 uL of nanoconjugate 
sample to 500 uL of 1:1 HNO3:HCl as above, and mixed thoroughly. Millipore water and multi-element 
internal standard (CLISS-1, Spex Certiprep, Metuchen, NJ, USA) containing 6Li, Sc, Y, In, Ho, Bi were 
added to produce a solution of 2% nitric acid (v/v), 2% HCl (v/v) and 5.0 ng/mL internal standard up to a 
total sample volume of 3 mL (Gd) and 10 mL (Au) after 20-fold dilution of original aliquot. Individual 
Au and Gd elemental standards were prepared at 0, 0.78125, 1.5625, 3.125, 6.25, 12.5, 25.0, 50.0, 100, 
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and 200 ng/mL concentrations with 2% nitric acid (v/v), 2% HCl (v/v) and 5.0 ng/mL internal standards 
up to a total sample volume of 5 mL.. Each sample was acquired using 1 survey run (10 sweeps) and 3 
main (peak jumping) runs (100 sweeps). The isotopes selected were 197Au, 156,157Gd and 115In, 165Ho, and 
209Bi (as internal standards for data interpolation and machine stability). 
 
NMRD Data: Water proton relaxation rates of solutions containing nanostar and nanosphere conjugates 
were measured from 0.01 to 40 MHz proton Larmor frequency using a fast field cycling Stelar 
relaxometer.  The relaxivity profiles of the DNA-Gd@stars and DNA-Gd@spheres were obtained after 
the subtraction of the diamagnetic 24-mer poly dT gold nanoconjugate equivalents and normalized to 
1mM Gd(III) concentration. 
 
Cell Culture: Pancreatic cancer cells (PANC-1, ATCC) were maintained in DMEM medium (Gibco) 
supplemented with 10% fetal bovine serum (FBS) (Invitrogen). Cells were grown in T25 flasks (VWR) at 
37 °C and 5% CO2. 
 
Quantification of Gd(III) Uptake in Cells: 30,000 PANC-1 cells were seeded in each well of a 24-well 
plate overnight. The cell culture media was replaced with varying concentrations (in triplicate) of DNA-
Gd@stars, DNA-Gd@spheres, or ProHance suspended in the serum-containing growth medium and 
incubated for 24 h at 37 °C. The CA-doped media was removed and the wells were washed 3x with ice- 
cold PBS followed by trypsinizaion. The cells were then washed twice more via centrifugation (900 xg, 5 
min) and resuspending in PBS. Finally, cells were counted with a hemacytometer then digested in 120 ul 
of 1:1 concentrated nitric acid: concentrated hydrochloric acid overnight. ICP-MS samples and standards 
were prepared as described above. 
 
Confocal Imaging of Cy3-Labeled DNA-Gd@stars and DNA-Gd@spheres: PANC-1 cells were 
grown on collagen coated coverslips then incubated for 24 hrs with 1.5 µM [Gd(III)] of DNA-Gd@stars 
and DNA-Gd@spheres in growth medium. Cells were washed 3x with ice cold PBS, fixed in 4% 
paraformaldehyde, and mounted on a glass slide with a drop of ProLong Gold antifade reagent 
(Invitrogen). The fixed samples were imaged on an inverted Zeiss 510 confocal microscope using a 40x 
water immersion objective and a 533 nm HeNe laser to excite the Cy3-labeled nanoconjugates. All 
microscope parameters (pinhole size, gain, offset, laser intensity) were kept constant between imaging 
DNA-Gd@star and DNA-Gd@sphere samples. The Cy3 channel was not post-processed. The blue DAPI 
channel was processed (despeckle, Gausian blur, adjust min/max) with FIJI to enhance visualization of 
the cell nuclei.  
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